logo
AI Icon𝛼SK or Search
ENTITY
Antengene

Antengene (6996 HK)

55
Analysis
Health Care • China
Antengene is a global, R&D-driven, commercial-stage biotech company focused on discovering, developing, manufacturing, and commercializing first-in-class/best-in-class therapeutics for hematologic malignancies and solid tumors. Its pipeline includes in-house discovered programs like ATG-022 and ATG-101, and its lead commercial asset is XPOVIO® (selinexor). The company also developed the AnTenGager® T cell engager platform. Antengene is headquartered in Shanghai, China, and was founded in 2017.
more
Company Presentation • 21 Aug 2026 18:30

H1 2026

Company Presentation • 20 Aug 2025 09:00

Study Update

Company Presentation • 22 Aug 2025 16:00

H1 2025

Company Presentation • 19 Dec 2023 20:00

Investor Presentation

Company Presentation • 01 Jun 2025 19:00

Jefferies Global Healthcare Conference 2025 Presentation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x